RxDoctor Payments Data

Adrian Ong, MD

Plastic Surgery within the Head & Neck · New York, NYNPI 1922461391

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,787 of the $3,435 with a category attached, or 81.1%. 8 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 58.2% of the total.

$3,435in general payments, 2019–2025

Across 55 payments — averaging $62.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Medical Device Business Services, Inc.$648
  • Johnson & Johnson$281
  • Stryker$166
  • Medtronic$165
  • Organogenesis Inc.$98
  • plus $79 from 2 others

What the payments were for

  • Food & beverage$2,78781%
  • Education$64819%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,435 in reported general payments places this provider in the 75th percentile of 45 plastic surgery within the head & neck providers in New York.

See all plastic surgery within the head & neck providers in New York

Medicare billing

Part B allowed, 2024
$18,343
Medicare patients
55
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate175$1,456
Ipratropium Bromide25$510
Azelastine Hcl33$441
Pantoprazole Sodium38$396
Mometasone Furoate14$193

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →